Clinical Trials / Studies


Clinical trials - also known as clinical studies or research protocols - are conducted to test whether a new drug, new prevention strategy, or new screening test is safe and effective in people. Participation is always voluntary. Baylor College of Medicine investigators conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions.


View Actively Recruiting Studies at Baylor College of Medicine trials on

Search for Clinical Trials

Ex Vivo T-Cell Depletion of Mobilized peripheral blood stem cells via CD34-Selection  Participants are being asked to take part in this study…
  • Cancer - All
  • Cancer - Stem Cell Transplant
Cell Therapy for High Risk T-cell Malignancies using CD7-Specific CAR Expressed on Non-Edited T cells (CRIMSON-NE) Patients eligible for this study…
  • Cancer - All
  • Cancer - Leukemia
  • Cancer - Non-Hodgkin Lymphoma
  • Cancer - Lymphoma
Phase I study of HER2 chimeric antigen receptor (CAR) T cells in combination with checkpoint blockade in patients with advanced sarcoma (HEROS 3.0)…
  • Cancer - All
  • Cancer - Sarcoma
Gore® cardioform septal occluder and antiplatelet medical management for reduction of recurrent stroke in patients with patent foramen ovale (pfo):…
  • Heart
  • Wearable Technology
The Amplatzer post-infarct muscular vsd occluder humanitarian device exemption (h070005) post approval study.
  • Heart
Hemodynamic-guided management of heart failure (Guide-HF).
  • Heart
A prospective, controlled, multi-center, post-approval trial to evaluate the long-term safety and effectiveness of augment injectable bone graft…
  • Bones/Joints/Muscles
Pliant pln-74809-psc-203: A randomized, double-blind, dose-ranging, placebo-controlled, phase 2a evaluation of the safety, tolerability, and…
  • Liver
Eiger eig-lnf-011 is a phase 3, matrix design, partially double-blind, randomized study of the efficacy and safety of 50 mg lonafarnib/ 100 mg…
  • Liver
A phase 2/3 open-label study to evaluate the safety, tolerability, efficacy and pk of Remdesivir in participants from birth to < 18 years of age…
  • Infectious Diseases/Immune System
  • Pediatrics